-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PagpWQbN3Ruzn0BgOmBPCdpjXPuJWBZtCkY/ALX4Hu+W49PimQzS+mujeYP28L+Y hGX+xDQ3CdGD+44AIPrV0A== 0001181431-09-058286.txt : 20091222 0001181431-09-058286.hdr.sgml : 20091222 20091222170959 ACCESSION NUMBER: 0001181431-09-058286 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090210 FILED AS OF DATE: 20091222 DATE AS OF CHANGE: 20091222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mead Johnson Nutrition Co CENTRAL INDEX KEY: 0001452575 STANDARD INDUSTRIAL CLASSIFICATION: FOOD & KINDRED PRODUCTS [2000] IRS NUMBER: 800318351 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2400 WEST LLOYD EXPRESSWAY CITY: EVANSVILLE STATE: IN ZIP: 47721-0001 BUSINESS PHONE: 8124295000 MAIL ADDRESS: STREET 1: 2400 WEST LLOYD EXPRESSWAY CITY: EVANSVILLE STATE: IN ZIP: 47721-0001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34251 FILM NUMBER: 091255850 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER NAME: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 3 1 rrd260710.xml FORM 3 X0203 3 2009-02-10 0 0001452575 Mead Johnson Nutrition Co MJN 0000014272 BRISTOL MYERS SQUIBB CO 345 PARK AVENUE NEW YORK NY 10154 0 0 1 0 Class A Common Stock 42344571 D Class B Common Stock 0 Class A Common Stock 127655429 I By E.R. Squibb & Sons, L.L.C. The Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no exercise or conversion price or expiration date. The reported securities are owned directly by E.R. Squibb & Sons, L.L.C., which is a wholly-owned subsidiary of Bristol-Myers Squibb Company. Bristol-Myers Squibb Company is an indirect beneficial owner of the reported securities. /s/ Sonia Vora, Assistant Corporate Secretary for Bristol-Myers Squibb Company 2009-12-22 -----END PRIVACY-ENHANCED MESSAGE-----